Home Journal Club	FAQ My Amedeo About Tranquillis Services	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Colorectal Neoplasms

Free Subscription Articles published in Eur J Cancer Retrieve available abstracts of 48 articles: HTML format Text format

Single Articles

March 2010
1. LI J , Hou N, Faried A, Tsutsumi S, et al
   Inhibition of autophagy augments 5-fluorouracil chemotherapy in human colon cancer in vitro and in vivo model.
   Eur J Cancer. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
2. ECONOMOPOULOS KP , Sergentanis TN
   GSTM1, GSTT1, GSTP1, GSTA1 and colorectal cancer risk: A comprehensive meta-analysis.
   Eur J Cancer. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
3. REBILLARD A , Jouan-Lanhouet S, Jouan E, Legembre P, et al
   Cisplatin-induced apoptosis involves a Fas-ROCK-ezrin-dependent actin remodelling in human colon cancer cells.
   Eur J Cancer. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   February 2010
4. STINTZING S , Hoffmann RT, Heinemann V, Kufeld M, et al
   Frameless single-session robotic radiosurgery of liver metastases in colorectal cancer patients.
   Eur J Cancer. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
5. DES GUETZ G , Nicolas P, Perret GY, Morere JF, et al
   Does delaying adjuvant chemotherapy after curative surgery for colorectal cancer impair survival? A meta-analysis.
   Eur J Cancer. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
6. BLINMAN P , Duric V, Nowak AK, Beale P, et al
   Adjuvant chemotherapy for early colon cancer: What survival benefits make it worthwhile?
   Eur J Cancer. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   January 2010
7. MAGNUSSON C , Mezhybovska M, Lorinc E, Fernebro E, et al
   Low expression of CysLT(1)R and high expression of CysLT(2)R mediate good prognosis in colorectal cancer.
   Eur J Cancer. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   December 2009
8. LUO Y , Ohmori H, Fujii K, Moriwaka Y, et al
   HMGB1 attenuates anti-metastatic defence of the liver in colorectal cancer.
   Eur J Cancer. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   
9. ARTELLS R , Moreno I, Diaz T, Martinez F, et al
   Tumour CD133 mRNA expression and clinical outcome in surgically resected colorectal cancer patients.
   Eur J Cancer. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   September 2009
10. WHISTANCE RN , Conroy T, Chie W, Costantini A, et al
    Clinical and psychometric validation of the EORTC QLQ-CR29 questionnaire module to assess health-related quality of life in patients with colorectal cancer.
    Eur J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
11. LOBJOIS V , Frongia C, Jozan S, Truchet I, et al
    Cell cycle and apoptotic effects of SAHA are regulated by the cellular microenvironment in HCT116 multicellular tumour spheroids.
    Eur J Cancer. 2009;45:2402-11.
    PubMed     Text format     Related articles    Abstract available
    
    
    
12. FIEBRICH HB , Brouwers AH, Koopmans KP, de Vries EG, et al
    Combining 6-fluoro-[18F]l-dihydroxyphenylalanine and [18F]fluoro-2-deoxy-d-glucose positron emission tomography for distinction of non-carcinoid malignancies in carcinoid patients.
    Eur J Cancer. 2009;45:2312-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    
13. JULLUMSTRO E , Lydersen S, Moller B, Dahl O, et al
    Duration of symptoms, stage at diagnosis and relative survival in colon and rectal cancer.
    Eur J Cancer. 2009;45:2383-90.
    PubMed     Text format     Related articles    Abstract available
    
    
    
14. KRAUS S , Arber N
    Screening for colorectal cancer, where are we now?
    Eur J Cancer. 2009;45 Suppl 1:422-4.
    PubMed     Text format     Related articles    Abstract available
    
    
    
15. COYLE VM , Johnston PG
    Genomic profiling of colorectal cancer.
    Eur J Cancer. 2009;45 Suppl 1:371-4.
    PubMed     Text format     Related articles   
    
    
    
16. KRAUS S , Arber N
    Colorectal cancer chemoprevention: ready for practice?
    Eur J Cancer. 2009;45 Suppl 1:360-6.
    PubMed     Text format     Related articles   
    
    
    
17. MACARULLA T , Capdevila J, Perez-Garcia J, Ramos FJ, et al
    New approaches and targets in advanced colorectal cancer.
    Eur J Cancer. 2009;45 Suppl 1:79-88.
    PubMed     Text format     Related articles   
    
    
    
18. PRENEN H , Tejpar S, Van Cutsem E
    Impact of molecular markers on treatment selection in advanced colorectal cancer.
    Eur J Cancer. 2009;45 Suppl 1:70-8.
    PubMed     Text format     Related articles   
    
    
    August 2009
19. FUSCO M , Pezzi A, Benatti P, Roncucci L, et al
    Clinical features and colorectal cancer survival: An attempt to explain differences between two different Italian regions.
    Eur J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
20. DAM LV , Hol L, Bekker-Grob EW, Steyerberg EW, et al
    What determines individuals' preferences for colorectal cancer screening programmes? A discrete choice experiment.
    Eur J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
21. GERTLER R , Rosenberg R, Schuster T, Friess H, et al
    Defining a high-risk subgroup with colon cancer stages I and II for possible adjuvant therapy.
    Eur J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
22. DENIS B , Gendre I, Aman F, Ribstein F, et al
    Colorectal cancer screening with the addition of flexible sigmoidoscopy to guaiac-based faecal occult blood testing: A French population-based controlled study (Wintzenheim trial).
    Eur J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    July 2009
23. GAO Y , Pan X, Su T, Mo Z, et al
    Glutathione S-transferase P1 Ile105Val polymorphism and colorectal cancer risk: A meta-analysis and HuGE review.
    Eur J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
24. OKINES A , Cunningham D
    Current perspective: Bevacizumab in colorectal cancer - A time for reappraisal?
    Eur J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
25. STANG A , Fischbach R, Teichmann W, Bokemeyer C, et al
    A systematic review on the clinical benefit and role of radiofrequency ablation as treatment of colorectal liver metastases.
    Eur J Cancer. 2009;45:1748-56.
    PubMed     Text format     Related articles    Abstract available
    
    
    June 2009
26. JACOB S , Ng W, Asghari R, Delaney GP, et al
    Estimation of an optimal chemotherapy utilisation rate for colon cancer: An evidence-based benchmark for cancer care.
    Eur J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
27. AKHDAR H , Loyer P, Rauch C, Corlu A, et al
    Involvement of Nrf2 activation in resistance to 5-fluorouracil in human colon cancer HT-29 cells.
    Eur J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
28. SOBRERO A
    Molecular markers of chemotherapy in advanced colorectal cancer: Back to square one.
    Eur J Cancer. 2009.
    PubMed     Text format     Related articles   
    
    
    
29. CUTHBERT RJ , Wilson JM, Scott N, Coletta PL, et al
    Differential CD74 (major histocompatibility complex Class II invariant chain) expression in mouse and human intestinal adenomas.
    Eur J Cancer. 2009;45:1654-63.
    PubMed     Text format     Related articles    Abstract available
    
    
    
30. VAN GILS P , van den Berg M, van Kranen H, de Wit AG, et al
    A literature review of assumptions on test characteristics and adherence in economic evaluations of colonoscopy and CT-colonography screening.
    Eur J Cancer. 2009;45:1554-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
31. LANGE MM , Marijnen CA, Maas CP, Putter H, et al
    Risk factors for sexual dysfunction after rectal cancer treatment.
    Eur J Cancer. 2009;45:1578-88.
    PubMed     Text format     Related articles    Abstract available
    
    
    May 2009
32. KOOPMAN M , Venderbosch S, Nagtegaal ID, van Krieken JH, et al
    A review on the use of molecular markers of cytotoxic therapy for colorectal cancer, what have we learned?
    Eur J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
33. KOOPMAN M , Venderbosch S, van Tinteren H, Ligtenberg MJ, et al
    Predictive and prognostic markers for the outcome of chemotherapy in advanced colorectal cancer, a retrospective analysis of the phase III randomised CAIRO study.
    Eur J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
34. DES GUETZ G , Schischmanoff O, Nicolas P, Perret GY, et al
    Does microsatellite instability predict the efficacy of adjuvant chemotherapy in colorectal cancer? A systematic review with meta-analysis.
    Eur J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
35. PEREZ-CABORNERO L , Velasco E, Infante M, Sanz D, et al
    A new strategy to screen MMR genes in Lynch Syndrome: HA-CAE, MLPA and RT-PCR.
    Eur J Cancer. 2009;45:1485-93.
    PubMed     Text format     Related articles    Abstract available
    
    
    
36. MEYER A , Merkel S, Bruckl W, Schellerer V, et al
    Cdc2 as prognostic marker in stage UICC II colon carcinomas.
    Eur J Cancer. 2009;45:1466-73.
    PubMed     Text format     Related articles    Abstract available
    
    
    
37. DEN DULK M , Putter H, Collette L, Marijnen CA, et al
    The abdominoperineal resection itself is associated with an adverse outcome: the European experience based on a pooled analysis of five European randomised clinical trials on rectal cancer.
    Eur J Cancer. 2009;45:1175-83.
    PubMed     Text format     Related articles    Abstract available
    
    
    April 2009
38. ROXBURGH CS , Salmond JM, Horgan PG, Oien KA, et al
    Tumour inflammatory infiltrate predicts survival following curative resection for node-negative colorectal cancer.
    Eur J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
39. HORST D , Kriegl L, Engel J, Jung A, et al
    CD133 and nuclear beta-catenin: The marker combination to detect high risk cases of low stage colorectal cancer.
    Eur J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
40. HEBBAR M , Adenis A, Revillion F, Duhamel A, et al
    E-selectin gene S128R polymorphism is associated with poor prognosis in patients with stage II or III colorectal cancer.
    Eur J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    March 2009
41. BRENNER H , Hoffmeister M, Brenner G, Altenhofen L, et al
    Expected reduction of colorectal cancer incidence within 8 years after introduction of the German screening colonoscopy programme: Estimates based on 1,875,708 screening colonoscopies.
    Eur J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    February 2009
42. SHITARA K , Matsuo K, Takahari D, Yokota T, et al
    Neutropaenia as a prognostic factor in metastatic colorectal cancer patients undergoing chemotherapy with first-line FOLFOX.
    Eur J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
43. CHAUVENET M , Lepage C, Jooste V, Cottet V, et al
    Prevalence of patients with colorectal cancer requiring follow-up or active treatment.
    Eur J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    January 2009
44. RAVIZZA R , Molteni R, Gariboldi MB, Marras E, et al
    Effect of HIF-1 modulation on the response of two- and three-dimensional cultures of human colon cancer cells to 5-fluorouracil.
    Eur J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
45. FREDERIKSEN BL , Osler M, Harling H, Ladelund S, et al
    The impact of socioeconomic factors on 30-day mortality following elective colorectal cancer surgery: A nationwide study.
    Eur J Cancer. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
46. NEAL CP , Mann CD, Sutton CD, Garcea G, et al
    Evaluation of the prognostic value of systemic inflammation and socioeconomic deprivation in patients with resectable colorectal liver metastases.
    Eur J Cancer. 2009;45:56-64.
    PubMed     Text format     Related articles    Abstract available
    
    
    November 2008
47. CLARK J , Cleator S, Goldin R, Lowdell C, et al
    Treatment of primary rectal squamous cell carcinoma by primary chemoradiotherapy: should surgery still be considered a standard of care?
    Eur J Cancer. 2008;44:2340-3.
    PubMed     Text format     Related articles    Abstract available
    
    
    September 2008
48. ESKENS FA , Sleijfer S
    The use of bevacizumab in colorectal, lung, breast, renal and ovarian cancer: Where does it fit?
    Eur J Cancer. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: